Unstable, and vasospastic angina
Acute myocardial infarction
Acute left ventricular failure
Lowering blood pressure
Severe hypertension with cardiac decompensation
Counter-induced coronary spasms
Increased ischemia tolerance during PTCA

Intravenous infusion of nitroglycerin should be performed in a hospital setting with continuous cardiovascular monitoring.

Nitronal aqueous can be infused in a non-companion manner using suitable or diluted equipment (such as saline, 5% glucose). When using the drug in combination with other injectable solutions, the manufacturer’s information about the relevant solution, including compatibility, contraindications, side effects and other drug interactions should be considered.

Nitronal aqueous in the form of 5 ml, 10 ml and 25 ml ampoules is stable for 3 years (in a closed container).

Nitronal aqueous in 50 ml vials, stable for 2 years (in closed container)

Nitronal aqueous should not be used after the expiration date

Nitronal aqueous should not be stored at temperatures above 25 ° C.